AVAV vs. CORT
Compare and contrast key facts about AeroVironment, Inc. (AVAV) and Corcept Therapeutics Incorporated (CORT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AVAV or CORT.
Correlation
The correlation between AVAV and CORT is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
AVAV vs. CORT - Performance Comparison
Loading data...
Key characteristics
AVAV:
-0.30
CORT:
1.43
AVAV:
-0.12
CORT:
3.93
AVAV:
0.98
CORT:
1.53
AVAV:
-0.30
CORT:
3.77
AVAV:
-0.60
CORT:
10.21
AVAV:
26.05%
CORT:
16.79%
AVAV:
50.15%
CORT:
122.13%
AVAV:
-61.02%
CORT:
-94.28%
AVAV:
-30.22%
CORT:
-34.27%
Fundamentals
AVAV:
$7.49B
CORT:
$7.96B
AVAV:
$1.16
CORT:
$1.15
AVAV:
141.46
CORT:
65.29
AVAV:
1.72
CORT:
0.61
AVAV:
10.09
CORT:
11.62
AVAV:
8.77
CORT:
11.40
AVAV:
$545.58M
CORT:
$685.45M
AVAV:
$216.60M
CORT:
$674.70M
AVAV:
$45.86M
CORT:
$111.33M
Returns By Period
In the year-to-date period, AVAV achieves a 6.63% return, which is significantly lower than CORT's 49.00% return. Over the past 10 years, AVAV has underperformed CORT with an annualized return of 20.15%, while CORT has yielded a comparatively higher 29.14% annualized return.
AVAV
6.63%
11.16%
-17.98%
-15.34%
20.21%
20.15%
CORT
49.00%
20.63%
44.86%
167.28%
39.16%
29.14%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AVAV vs. CORT — Risk-Adjusted Performance Rank
AVAV
CORT
AVAV vs. CORT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for AeroVironment, Inc. (AVAV) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
AVAV vs. CORT - Dividend Comparison
Neither AVAV nor CORT has paid dividends to shareholders.
Drawdowns
AVAV vs. CORT - Drawdown Comparison
The maximum AVAV drawdown since its inception was -61.02%, smaller than the maximum CORT drawdown of -94.28%. Use the drawdown chart below to compare losses from any high point for AVAV and CORT. For additional features, visit the drawdowns tool.
Loading data...
Volatility
AVAV vs. CORT - Volatility Comparison
The current volatility for AeroVironment, Inc. (AVAV) is 9.89%, while Corcept Therapeutics Incorporated (CORT) has a volatility of 12.39%. This indicates that AVAV experiences smaller price fluctuations and is considered to be less risky than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
AVAV vs. CORT - Financials Comparison
This section allows you to compare key financial metrics between AeroVironment, Inc. and Corcept Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AVAV vs. CORT - Profitability Comparison
AVAV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AeroVironment, Inc. reported a gross profit of 63.20M and revenue of 167.64M. Therefore, the gross margin over that period was 37.7%.
CORT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported a gross profit of 154.81M and revenue of 157.21M. Therefore, the gross margin over that period was 98.5%.
AVAV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AeroVironment, Inc. reported an operating income of -3.09M and revenue of 167.64M, resulting in an operating margin of -1.8%.
CORT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported an operating income of 3.42M and revenue of 157.21M, resulting in an operating margin of 2.2%.
AVAV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AeroVironment, Inc. reported a net income of -1.75M and revenue of 167.64M, resulting in a net margin of -1.1%.
CORT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported a net income of 20.29M and revenue of 157.21M, resulting in a net margin of 12.9%.